Clinical identification of malignant pleural effusions

Area of Science:

• Pulmonology
• Oncology
• Diagnostic Medicine

Background:

• Pleural effusions often indicate advanced cancer, necessitating accurate diagnostic tools.
• Current diagnostic markers for malignant pleural effusions are insufficient for risk assessment and streamlined decision-making.

Purpose of the Study:

• To develop and validate a novel scoring system, the Malignant Pleural Effusion Detection (MAPED) score, for identifying malignant pleural effusions.
• To assess the diagnostic accuracy and clinical utility of the MAPED score compared to traditional methods like cytology.

Main Methods:

• Retrospective analysis of 323 patients with pleural effusion to identify key diagnostic variables.
• Development of the 5-point MAPED score using logistic regression and random forests.
• Validation of the MAPED score in an independent cohort of 238 patients.

Main Results:

• The MAPED score, incorporating age, effusion size, neutrophil count, protein, and LDH levels, demonstrated high diagnostic power (AUC=0.819 in derivation, AUC=0.723 in validation).
• MAPED showed improved discrimination over cytology and provided clinical benefit.
• The score successfully identified 79% of cytology-negative malignant effusions.

Conclusions:

• The MAPED score is a reliable tool for diagnosing malignant pleural effusions.
• It serves as an effective adjunct to cytology, enhancing diagnostic efficiency.
• The MAPED score is safe, cost-effective, and aids in streamlining patient management.